Immunotherapy is one of the most promising areas of cancer treatment, with hundreds of clinical trials in the works. Unlike chemotherapy, which aims to kill cancer cells outright, immunotherapy spurs the immune system to attack cancerous cells. Immunotherapy drugs cover a wide spectrum, from checkpoint inhibitors to cancer vaccines. Epic community members like MD Anderson and Memorial Sloan-Kettering are conducting groundbreaking research in this new field, which is already producing results in difficult-to-treat cancer cases.
Read more here.